5 Key Takeaways

• 1

  PGK1 is identified as a key enzyme in addressing metabolic deficits in Parkinson's disease.

• 2

  Increasing PGK1 expression may protect dopamine-producing neurons and enhance ATP synthesis.

• 3

  Upregulating PGK1 led to a 14% decrease in ATP depletion during synaptic activity under low-glucose conditions.

• 4

  In vivo, PGK1 expression resulted in a 2.5-fold increase in tyrosine hydroxylase-positive neurons after a 6-OHDA injection.

• 5

  The study highlights the interplay between PGK1 and PARK7/DJ-1 in maintaining neuronal energy homeostasis.